Search - tctmd.com

Displaying 101 - 120 of 127

Sort: Relevancy | Date

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Daily News

Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes

Shelley Wood

April 13, 2021

News Daily News

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Caitlin E. Cox

April 12, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

L.A. McKeown

April 07, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

Caitlin E. Cox

March 24, 2021

News Daily News

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Michael O'Riordan

March 04, 2021

News Daily News

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis

Todd Neale

March 02, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

CV Complications of Malaria Rare but Portend Poor Prognosis

Michael O'Riordan

February 22, 2021

News Daily News

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

Todd Neale

February 16, 2021

News Daily News

CABANA Supports Use of AF Ablation in Patients With Heart Failure

Todd Neale

February 12, 2021

News Daily News

Did Regional Differences Muddy Results in COMMANDER-HF?

L.A. McKeown

February 04, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

Michael O'Riordan

January 25, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

Advertisement

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

April 2021 News Roundup

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

TCTMD’s Top 10 Most Popular Stories for March 2021

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Roughly 80% of ESC Guideline Writers Have Financial COIs

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis

March 2021 News Roundup

CV Complications of Malaria Rare but Portend Poor Prognosis

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

CABANA Supports Use of AF Ablation in Patients With Heart Failure

Did Regional Differences Muddy Results in COMMANDER-HF?

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

FDA Approves Vericiguat for High-risk Patients With HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content